6483 logo

Original BioMedicals Co., Ltd. Stock Price

TPEX:6483 Community·NT$965.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6483 Share Price Performance

NT$14.55
2.70 (22.78%)
NT$14.55
2.70 (22.78%)
Price NT$14.55

6483 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

Original BioMedicals Co., Ltd. Key Details

NT$381.0k

Revenue

NT$75.0k

Cost of Revenue

NT$306.0k

Gross Profit

NT$90.6m

Other Expenses

-NT$90.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-1.36
80.32%
-23,699.74%
0%
View Full Analysis

About 6483

Founded
2011
Employees
23
CEO
Cliff C. Wang
WebsiteView website
www.i-obm.com

Original BioMedicals Co., Ltd., engages in the development of new drugs with non-new ingredients in Taiwan. It develops OBM-A01, for the treatment of acute radiation injury, including nuclear radiation and solar radiation exposed in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; and CCM-CL, a cyclic polypeptide antibiotic. The company was founded in 2011 and is based in Tainan City, Taiwan.

Recent 6483 News & Updates

Recent updates

No updates